Works about HISTONE deacetylase inhibitors
Results: 1795
Advances in epigenetic treatment of adult T-cell leukemia/lymphoma: a comprehensive review.
- Published in:
- Clinical Epigenetics, 2025, v. 17, n. 1, p. 1, doi. 10.1186/s13148-025-01841-z
- By:
- Publication type:
- Article
Effect of Curcumin Pretreatment on the Susceptibility of Cryptococcus neoformans to Photodynamic Therapy Mediated by Aluminum Phthalocyanine in Nanoemulsion.
- Published in:
- Pharmaceuticals (14248247), 2025, v. 18, n. 2, p. 240, doi. 10.3390/ph18020240
- By:
- Publication type:
- Article
Cellular Epigenetic Targets and Epidrugs in Breast Cancer Therapy: Mechanisms, Challenges, and Future Perspectives.
- Published in:
- Pharmaceuticals (14248247), 2025, v. 18, n. 2, p. 207, doi. 10.3390/ph18020207
- By:
- Publication type:
- Article
Natural Compounds and Histone Deacetylase Inhibitors: A Combined Approach Against mCRPC Cells.
- Published in:
- Biomedicines, 2025, v. 13, n. 2, p. 296, doi. 10.3390/biomedicines13020296
- By:
- Publication type:
- Article
Chidamide and venetoclax synergistically regulate the Wnt/β-catenin pathway by MYCN/DKK3 in B-ALL.
- Published in:
- Annals of Hematology, 2025, v. 104, n. 1, p. 489, doi. 10.1007/s00277-024-06110-2
- By:
- Publication type:
- Article
Manipulating histone acetylation leads to antitumor effects in hemangiosarcoma cells.
- Published in:
- Veterinary & Comparative Oncology, 2022, v. 20, n. 4, p. 805, doi. 10.1111/vco.12840
- By:
- Publication type:
- Article
Pancreatic Cancer.
- Published in:
- Innovation, 2011, v. 10, n. 3, p. 47
- By:
- Publication type:
- Article
Masking the Bioactivity of Hydroxamic Acids by Coordination to Cobalt: Towards Bioreductive Anticancer Agents.
- Published in:
- Chemistry - A European Journal, 2024, v. 30, n. 46, p. 1, doi. 10.1002/chem.202401724
- By:
- Publication type:
- Article
Bioorthogonal Drug Release from Nanometric Micelles in Living Cells.
- Published in:
- Chemistry - A European Journal, 2023, v. 29, n. 43, p. 1, doi. 10.1002/chem.202301359
- By:
- Publication type:
- Article
A Multitargeted Approach: Organorhodium Anticancer Agent Based on Vorinostat as a Potent Histone Deacetylase Inhibitor.
- Published in:
- Angewandte Chemie, 2020, v. 132, n. 34, p. 14717, doi. 10.1002/ange.202005758
- By:
- Publication type:
- Article
Frontispiz: Potent Dual BET/HDAC Inhibitors for Efficient Treatment of Pancreatic Cancer.
- Published in:
- Angewandte Chemie, 2020, v. 132, n. 8, p. N.PAG, doi. 10.1002/ange.202080861
- By:
- Publication type:
- Article
Potent Dual BET/HDAC Inhibitors for Efficient Treatment of Pancreatic Cancer.
- Published in:
- Angewandte Chemie, 2020, v. 132, n. 8, p. 3052, doi. 10.1002/ange.201915896
- By:
- Publication type:
- Article
In vitro-based doubled haploid production: recent improvements.
- Published in:
- Euphytica, 2020, v. 216, n. 5, p. 1, doi. 10.1007/s10681-020-02609-7
- By:
- Publication type:
- Article
The roles of histone deacetylases in kidney development and disease.
- Published in:
- Clinical & Experimental Nephrology, 2021, v. 25, n. 3, p. 215, doi. 10.1007/s10157-020-01995-5
- By:
- Publication type:
- Article
Changes in uridine 5′‐diphospho‐glucuronosyltransferase 1A6 expression by histone deacetylase inhibitor valproic acid.
- Published in:
- Biopharmaceutics & Drug Disposition, 2022, v. 43, n. 5, p. 175, doi. 10.1002/bdd.2328
- By:
- Publication type:
- Article
Histone deacetylase inhibitors suppress transdifferentiation of gonadotrophs to prolactin cells and proliferation of prolactin cells induced by diethylstilbestrol in male mouse pituitary.
- Published in:
- Histochemistry & Cell Biology, 2019, v. 151, n. 4, p. 291, doi. 10.1007/s00418-018-1760-z
- By:
- Publication type:
- Article
Transcriptional signatures mediated by acetylation overlap with early-stage Alzheimer's disease.
- Published in:
- Experimental Brain Research, 2012, v. 221, n. 3, p. 287, doi. 10.1007/s00221-012-3172-y
- By:
- Publication type:
- Article
Vorinostat and Mithramycin A in combination therapy as an interesting strategy for the treatment of Sézary T lymphoma: a transcriptomic approach.
- Published in:
- Archives of Dermatological Research, 2017, v. 309, n. 8, p. 611, doi. 10.1007/s00403-017-1761-0
- By:
- Publication type:
- Article
Anticancer Identification and Molecular Docking of Cowanol from Garcinia fusca Against Histone Deacetylase Domains.
- Published in:
- Trends in Sciences, 2024, v. 21, n. 8, p. 1, doi. 10.48048/tis.2024.7807
- By:
- Publication type:
- Article
Identification and characterization of the spiruchostatin biosynthetic gene cluster enable yield improvement by overexpressing a transcriptional activator.
- Published in:
- Journal of Industrial Microbiology & Biotechnology, 2014, v. 41, n. 9, p. 1457, doi. 10.1007/s10295-014-1474-8
- By:
- Publication type:
- Article
Aryl butenoic acid derivatives as a new class of histone deacetylase inhibitors: synthesis, in vitro evaluation, and molecular docking studies.
- Published in:
- Turkish Journal of Chemistry, 2014, v. 38, n. 2, p. 338, doi. 10.3906/kim-1305-56
- By:
- Publication type:
- Article
Predicting Response to Histone Deacetylase Inhibitors Using High-Throughput Genomics.
- Published in:
- 2015
- By:
- Publication type:
- journal article
FDA Approves New Agent for Multiple Myeloma.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2015, v. 107, n. 6, p. 5, doi. 10.1093/jnci/djv165
- By:
- Publication type:
- Article
Synthesis and biological evaluation of ortho-phenyl phenylhydroxamic acids containing phenothiazine with improved selectivity for class IIa histone deacetylases.
- Published in:
- Journal of Enzyme Inhibition & Medicinal Chemistry, 2024, v. 39, n. 1, p. 1, doi. 10.1080/14756366.2024.2406025
- By:
- Publication type:
- Article
Discovery of novel anaplastic lymphoma kinase (ALK) and histone deacetylase (HDAC) dual inhibitors exhibiting antiproliferative activity against non-small cell lung cancer.
- Published in:
- Journal of Enzyme Inhibition & Medicinal Chemistry, 2024, v. 39, n. 1, p. 1, doi. 10.1080/14756366.2024.2318645
- By:
- Publication type:
- Article
Discovery of novel polysubstituted N-alkyl acridone analogues as histone deacetylase isoform-selective inhibitors for cancer therapy.
- Published in:
- Journal of Enzyme Inhibition & Medicinal Chemistry, 2023, v. 38, n. 1, p. 1, doi. 10.1080/14756366.2023.2206581
- By:
- Publication type:
- Article
Phosphorus containing analogues of SAHA as inhibitors of HDACs.
- Published in:
- Journal of Enzyme Inhibition & Medicinal Chemistry, 2022, v. 37, n. 1, p. 1315, doi. 10.1080/14756366.2022.2063281
- By:
- Publication type:
- Article
Discovery and SAR analysis of 5-chloro-4-((substituted phenyl)amino)pyrimidine bearing histone deacetylase inhibitors.
- Published in:
- Journal of Enzyme Inhibition & Medicinal Chemistry, 2022, v. 37, n. 1, p. 1918, doi. 10.1080/14756366.2022.2097446
- By:
- Publication type:
- Article
Benzenesulfonamides with different rigidity-conferring linkers as carbonic anhydrase inhibitors: an insight into the antiproliferative effect on glioblastoma, pancreatic, and breast cancer cells.
- Published in:
- Journal of Enzyme Inhibition & Medicinal Chemistry, 2022, v. 37, n. 1, p. 1857, doi. 10.1080/14756366.2022.2091557
- By:
- Publication type:
- Article
Inhibitors of histone deacetylase 6 based on a novel 3-hydroxy-isoxazole zinc binding group.
- Published in:
- Journal of Enzyme Inhibition & Medicinal Chemistry, 2021, v. 36, n. 1, p. 2080, doi. 10.1080/14756366.2021.1981306
- By:
- Publication type:
- Article
Ring size changes in the development of class I HDAC inhibitors.
- Published in:
- Journal of Enzyme Inhibition & Medicinal Chemistry, 2021, v. 36, n. 1, p. 1386, doi. 10.1080/14756366.2021.1941920
- By:
- Publication type:
- Article
Molecular design, synthesis and in vitro biological evaluation of thienopyrimidine–hydroxamic acids as chimeric kinase HDAC inhibitors: a challenging approach to combat cancer.
- Published in:
- Journal of Enzyme Inhibition & Medicinal Chemistry, 2021, v. 36, n. 1, p. 1290, doi. 10.1080/14756366.2021.1933465
- By:
- Publication type:
- Article
Discovery of potent histone deacetylase inhibitors with modified phenanthridine caps.
- Published in:
- Journal of Enzyme Inhibition & Medicinal Chemistry, 2021, v. 36, n. 1, p. 707, doi. 10.1080/14756366.2021.1892089
- By:
- Publication type:
- Article
Discovery of indole-3-butyric acid derivatives as potent histone deacetylase inhibitors.
- Published in:
- Journal of Enzyme Inhibition & Medicinal Chemistry, 2021, v. 36, n. 1, p. 425, doi. 10.1080/14756366.2020.1870457
- By:
- Publication type:
- Article
Identification of histone deacetylase inhibitors with (arylidene)aminoxy scaffold active in uveal melanoma cell lines.
- Published in:
- Journal of Enzyme Inhibition & Medicinal Chemistry, 2021, v. 36, n. 1, p. 34, doi. 10.1080/14756366.2020.1835883
- By:
- Publication type:
- Article
A potentiated cooperation of carbonic anhydrase IX and histone deacetylase inhibitors against cancer.
- Published in:
- Journal of Enzyme Inhibition & Medicinal Chemistry, 2020, v. 35, n. 1, p. 391, doi. 10.1080/14756366.2019.1706090
- By:
- Publication type:
- Article
The discovery of novel HDAC3 inhibitors via virtual screening and in vitro bioassay.
- Published in:
- Journal of Enzyme Inhibition & Medicinal Chemistry, 2018, v. 33, n. 1, p. 525, doi. 10.1080/14756366.2018.1437156
- By:
- Publication type:
- Article
Zinc binding groups for histone deacetylase inhibitors.
- Published in:
- Journal of Enzyme Inhibition & Medicinal Chemistry, 2018, v. 33, n. 1, p. 714, doi. 10.1080/14756366.2017.1417274
- By:
- Publication type:
- Article
5-Membered cyclic hydroxamic acids as HDAC inhibitors.
- Published in:
- Journal of Enzyme Inhibition & Medicinal Chemistry, 2015, v. 30, n. 2, p. 216, doi. 10.3109/14756366.2014.912214
- By:
- Publication type:
- Article
Synthesis, bioevaluation and docking study of 5-substitutedphenyl-1,3,4-thiadiazole-based hydroxamic acids as histone deacetylase inhibitors and antitumor agents.
- Published in:
- Journal of Enzyme Inhibition & Medicinal Chemistry, 2014, v. 29, n. 5, p. 611, doi. 10.3109/14756366.2013.832238
- By:
- Publication type:
- Article
Discovery of a series of hydroximic acid derivatives as potent histone deacetylase inhibitors.
- Published in:
- Journal of Enzyme Inhibition & Medicinal Chemistry, 2014, v. 29, n. 4, p. 582, doi. 10.3109/14756366.2013.827678
- By:
- Publication type:
- Article
Quinolone-based HDAC inhibitors.
- Published in:
- Journal of Enzyme Inhibition & Medicinal Chemistry, 2014, v. 29, n. 4, p. 555, doi. 10.3109/14756366.2013.827675
- By:
- Publication type:
- Article
Discovery of a series of small molecules as potent histone deacetylase inhibitors.
- Published in:
- Journal of Enzyme Inhibition & Medicinal Chemistry, 2014, v. 29, n. 3, p. 333, doi. 10.3109/14756366.2013.780237
- By:
- Publication type:
- Article
Repurposing Belinostat for Alleviation of Atopic Dermatitis.
- Published in:
- 2021
- By:
- Publication type:
- Letter
Beyond PD-1 Immunotherapy in Malignant Melanoma.
- Published in:
- Dermatology & Therapy, 2019, v. 9, n. 2, p. 243, doi. 10.1007/s13555-019-0292-3
- By:
- Publication type:
- Article
Low NCOR2 levels in multiple myeloma patients drive multidrug resistance via MYC upregulation.
- Published in:
- Blood Cancer Journal, 2021, v. 11, n. 12, p. 1, doi. 10.1038/s41408-021-00589-y
- By:
- Publication type:
- Article
The combination of CUDC-907 and gilteritinib shows promising in vitro and in vivo antileukemic activity against FLT3-ITD AML.
- Published in:
- Blood Cancer Journal, 2021, v. 11, n. 6, p. 1, doi. 10.1038/s41408-021-00502-7
- By:
- Publication type:
- Article
Long-term safety and efficacy of givinostat in polycythemia vera: 4-year mean follow up of three phase 1/2 studies and a compassionate use program.
- Published in:
- Blood Cancer Journal, 2021, v. 11, n. 3, p. 1, doi. 10.1038/s41408-021-00445-z
- By:
- Publication type:
- Article
Trichostatin A promotes de novo shoot regeneration from Arabidopsis root explants via a cytokinin related pathway.
- Published in:
- Scientific Reports, 2025, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-84860-9
- By:
- Publication type:
- Article
Sirtuin inhibitors reduce intracellular growth of M. tuberculosis in human macrophages via modulation of host cell immunity.
- Published in:
- Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-79136-1
- By:
- Publication type:
- Article